What are the implications of progesterone therapy for women with metabolic syndrome, including its effects on insulin sensitivity, lipid profiles, or inflammation levels?
Gaurav ChauhanContributor
What are the implications of progesterone therapy for women with metabolic syndrome?
Share
Progesterone therapy can improve insulin sensitivity and lipid profiles in women with metabolic syndrome, potentially reducing cardiovascular risk.
Progesterone treatment in metabolic syndrome may decrease inflammation, aiding in the management of weight and glucose levels.
In women with metabolic syndrome, progesterone therapy might exacerbate symptoms by affecting lipid levels and insulin sensitivity adversely.
1. Progesterone therapy may improve insulin sensitivity and reduce inflammation but can worsen lipid profiles in women with metabolic syndrome.
2. Progesterone therapy in metabolic syndrome often presents a mixed outcome; it can enhance insulin response and decrease inflammation, but it may negatively impact lipid profiles.